Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay
Arantxa Valdivia, Ignacio Torres, Dixie Huntley, María Jesús Alcaraz, Eliseo Albert, Javier Colomina, Josep Ferrer, Arturo Carratalá, David Navarro
doi: https://doi.org/10.1101/2020.06.23.20138016
Arantxa Valdivia
1Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain
Ignacio Torres
1Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain
Dixie Huntley
1Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain
María Jesús Alcaraz
1Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain
Eliseo Albert
1Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain
Javier Colomina
1Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain
Josep Ferrer
1Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain
Arturo Carratalá
2Medical Biochemistry and Clinical Analysis Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain
David Navarro
1Microbiology Service, Hospital Clínico Universitario, INCLIVA Research Institute, Valencia, Spain
3Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain
Data Availability
The data that support the findings of this study are available from the corresponding author, [author initials], upon reasonable request
Posted June 23, 2020.
Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay
Arantxa Valdivia, Ignacio Torres, Dixie Huntley, María Jesús Alcaraz, Eliseo Albert, Javier Colomina, Josep Ferrer, Arturo Carratalá, David Navarro
medRxiv 2020.06.23.20138016; doi: https://doi.org/10.1101/2020.06.23.20138016
Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay
Arantxa Valdivia, Ignacio Torres, Dixie Huntley, María Jesús Alcaraz, Eliseo Albert, Javier Colomina, Josep Ferrer, Arturo Carratalá, David Navarro
medRxiv 2020.06.23.20138016; doi: https://doi.org/10.1101/2020.06.23.20138016
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2767)
- Dermatology (236)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4284)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2765)
- Health Policy (1024)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4061)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6665)
- Radiology and Imaging (1455)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)